Keith: 

 

Best thing to do would be to contact the person listed in the announcement (I have copied below) prior to doing the letter of intent (which I just know has been done already)……

 

Jane L. Peterson, Ph.D.
National Human Genome Research Institute
 National Institutes of Health
5635 Fishers Lane, Suite 4076, MSC 9305
Bethesda, MD 20892-9305
Phone: 301 496 7531
Fax: 301 480 2770
Email: xxxxxx@nih.gov

 

 

Also, it mentions “bi- or multi-national institutions” in the announcement.  Seems that they want an institution in Africa to be prime, but doesn’t preclude an American institution’s participation (as a sub?)  Aside from the science, it could help to strengthen the admin structure at the prime institution.  As is quoted in the announcement, there are monies available for administrative support and learning/implementation by the end of year one for the prime African institution.

 

Hope this helps.

 

jay throp,

Consultant Administrator

xxxxxx@tufts.edu

 

 

I have a PI who is interested in submitting an application to NIH for RFA-RM-11-008, Human Heredity and Health in Africa (H3Africa): Collaborative Centers (U54).  We’re wondering about the eligibility of domestic institutions for this.  Under the FOA purpose it says:

 

This NIH Funding Opportunity Announcement (FOA), supported by funds from the NIH Common Fund (Common Fund) and participating NIH Institute(s) and Center(s), invites applications from foreign Institutions in African countries who wish to develop the study of genomic/genetic/environmental contributors of human health and disease within Africa, using cutting edge research tools to understand health and diseases affecting African populations more completely and increase capacity for biomedical research, in terms of building infrastructure (including data and research resources), genomic proficiency of researchers and numbers of trainees.  In partnership with the Wellcome Trust, the H3Africa initiative is focused on supporting these efforts as part of an effort to promote sustainable research in Africa that will promote health and combat disease.

 

From this, one may think that domestic institutions are not eligible.  However, when I look at the section III.1, eligible organizations, it says Non-domestic (non-U.S.) Entities (Foreign Institutions).  Below that it defines Foreign Institutions as:

 

·         Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

·         Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

·         Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

 

When you look at the definition of foreign components in the GPS, it states that it's performance of any significant scientific element or segment of a project outside of the United States. 

 

I'm just wondering if you think someone here could be the PI, but have the vast majority of the work done at the foreign site (the foreign component). 

 

Does anyone have any experience with such situations or is anyone planning on submitting to this RFA?  Any help would be appreciated. 

 

Thanks,

 

Keith.

 

Keith Page

Research Administrator

The Genome Institute | Washington University School of Medicine  

T: (314) 286-1955  |  E: xxxxxx@genome.wustl.edu

 

 

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.healthresearch.org (click on the "LISTSERV" link in the upper right corner)

A link directly to helpful tips: http://tinyurl.com/resadm-l-help ======================================================================